Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nos

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Revista Espanola De Enfermedades Digestivas|August 1, 1991
[Calcification of the portal vein associated with hepatocarcinoma]A Del Val, P Nos, L Martí-Bonmatí, et al.
Gastroenterologia Y Hepatologia|March 3, 2001
[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]P Nos, J Hinojosa, V Aguilera, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1995
Endoscopic sclerotherapy versus oesophageal transection in the prevention of variceal rebleedingP Nos, T Sala, V Pertejo, et al.
Revista Espanola De Enfermedades Digestivas|March 1, 1991
[Adult celiac disease and hepatopathy]M J Morillas, E Gaspar, J R Moles, et al.
Revista Espanola De Enfermedades Digestivas|February 12, 1999
Relationship between smoking and colonic involvement in inflammatory bowel diseaseM Bustamante, P Nos, M Hoyos, et al.
European Journal of Gastroenterology & Hepatology|April 11, 2001
Evolutive pattern in Crohn's disease: a simplified index using clinical parameters predicts obstructive behaviourJ Hinojosa, P Nos, J J Ramírez, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?E Domènech, J Hinojosa, P Nos, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 1995
[Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]J Hinojosa, J R Molés, P Nos, et al.
Clinical and Experimental Immunology|December 2, 2017
Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utilityE Cerrillo, I Moret, M Iborra, et al.
Revista Espanola De Enfermedades Digestivas|July 1, 1996
[Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history]P Nos, L Argüello, M Hoyos, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Revista Espanola De Enfermedades Digestivas|August 1, 1991
[Calcification of the portal vein associated with hepatocarcinoma]A Del Val, P Nos, L Martí-Bonmatí, et al.
Gastroenterologia Y Hepatologia|March 3, 2001
[Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]P Nos, J Hinojosa, V Aguilera, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1995
Endoscopic sclerotherapy versus oesophageal transection in the prevention of variceal rebleedingP Nos, T Sala, V Pertejo, et al.
Revista Espanola De Enfermedades Digestivas|March 1, 1991
[Adult celiac disease and hepatopathy]M J Morillas, E Gaspar, J R Moles, et al.
Revista Espanola De Enfermedades Digestivas|February 12, 1999
Relationship between smoking and colonic involvement in inflammatory bowel diseaseM Bustamante, P Nos, M Hoyos, et al.
European Journal of Gastroenterology & Hepatology|April 11, 2001
Evolutive pattern in Crohn's disease: a simplified index using clinical parameters predicts obstructive behaviourJ Hinojosa, P Nos, J J Ramírez, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2005
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?E Domènech, J Hinojosa, P Nos, et al.
Revista Espanola De Enfermedades Digestivas|November 1, 1995
[Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]J Hinojosa, J R Molés, P Nos, et al.
Clinical and Experimental Immunology|December 2, 2017
Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utilityE Cerrillo, I Moret, M Iborra, et al.
Revista Espanola De Enfermedades Digestivas|July 1, 1996
[Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history]P Nos, L Argüello, M Hoyos, et al.
Pageof 6